Bowen Acquisition Corp is planning a business combination with Shenzhen Qianzhi BioTechnology Co. Ltd., with a shareholder meeting set for January 13, 2025, to approve the deal and another meeting on January 7, 2025, to discuss extending the merger deadline to April 14, 2025.